Many oncogene products exert their effect through activation of the Ras-Raf-ERK pathway; therefore, we can speculate that constitutive activation of Ras or Raf and the resulting ERK activation may contribute to the loss of contact inhibition of cancer cells. Here, MAPK1 is linked to cancer.